Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer

Yunhee Cho, Hyun Woo Lee, Hyeok Gu Kang, Hye Young Kim, Seok Jun Kim, Kyung Hee Chun

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

CD44 plays a role in the progression of tumors and is expressed in cancer stem cells (CSCs). However, the mechanisms underlying the crosstalk of CD44 with stemness genes in CSC maintenance remains unclear. In this study, we demonstrated how the cleaved intracellular domain of CD44 (CD44ICD) activates stemness factors such as Nanog, Sox2 and Oct4, and contributes to the tumorigenesis of breast cancer. We have found that the overexpression of CD44ICD increased mammosphere formation in breast cancer cells. Treatment with a γ-secretase inhibitor (GSI), which blocks the cleavage of CD44ICD, interfered with mammosphere formation. Interestingly, CD44ICD decreased the expression levels and nuclear localization of stemness factors, but overexpression of CD44ICD reversed these effects. In addition, we showed that nuclear localization of CD44ICD is important for transcriptional activation of the stemness factors. Furthermore, CD44ICD-overexpressed cells exhibited strong tumorigenecity and greater metastatic potential than did the control cells or CD44-depleted cells in vivo in mice models. Taken together, it was supposed that CD44 promotes tumorigenesis through the interaction and nuclear-translocation of its intracellular domain and stemness factors. We suggest that the prevention of cleavage and nuclear-translocation of CD44ICD is a potential target in treating breast cancer.

Original languageEnglish
Pages (from-to)8709-8721
Number of pages13
JournalOncotarget
Volume6
Issue number11
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Carcinogenesis
Breast Neoplasms
Neoplastic Stem Cells
Amyloid Precursor Protein Secretases
Transcriptional Activation
Maintenance
Genes
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Cho, Yunhee ; Lee, Hyun Woo ; Kang, Hyeok Gu ; Kim, Hye Young ; Kim, Seok Jun ; Chun, Kyung Hee. / Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer. In: Oncotarget. 2015 ; Vol. 6, No. 11. pp. 8709-8721.
@article{b856cf2a1373434b834aa04d3f844fdc,
title = "Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer",
abstract = "CD44 plays a role in the progression of tumors and is expressed in cancer stem cells (CSCs). However, the mechanisms underlying the crosstalk of CD44 with stemness genes in CSC maintenance remains unclear. In this study, we demonstrated how the cleaved intracellular domain of CD44 (CD44ICD) activates stemness factors such as Nanog, Sox2 and Oct4, and contributes to the tumorigenesis of breast cancer. We have found that the overexpression of CD44ICD increased mammosphere formation in breast cancer cells. Treatment with a γ-secretase inhibitor (GSI), which blocks the cleavage of CD44ICD, interfered with mammosphere formation. Interestingly, CD44ICD decreased the expression levels and nuclear localization of stemness factors, but overexpression of CD44ICD reversed these effects. In addition, we showed that nuclear localization of CD44ICD is important for transcriptional activation of the stemness factors. Furthermore, CD44ICD-overexpressed cells exhibited strong tumorigenecity and greater metastatic potential than did the control cells or CD44-depleted cells in vivo in mice models. Taken together, it was supposed that CD44 promotes tumorigenesis through the interaction and nuclear-translocation of its intracellular domain and stemness factors. We suggest that the prevention of cleavage and nuclear-translocation of CD44ICD is a potential target in treating breast cancer.",
author = "Yunhee Cho and Lee, {Hyun Woo} and Kang, {Hyeok Gu} and Kim, {Hye Young} and Kim, {Seok Jun} and Chun, {Kyung Hee}",
year = "2015",
month = "1",
day = "1",
doi = "10.18632/oncotarget.3325",
language = "English",
volume = "6",
pages = "8709--8721",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "11",

}

Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer. / Cho, Yunhee; Lee, Hyun Woo; Kang, Hyeok Gu; Kim, Hye Young; Kim, Seok Jun; Chun, Kyung Hee.

In: Oncotarget, Vol. 6, No. 11, 01.01.2015, p. 8709-8721.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer

AU - Cho, Yunhee

AU - Lee, Hyun Woo

AU - Kang, Hyeok Gu

AU - Kim, Hye Young

AU - Kim, Seok Jun

AU - Chun, Kyung Hee

PY - 2015/1/1

Y1 - 2015/1/1

N2 - CD44 plays a role in the progression of tumors and is expressed in cancer stem cells (CSCs). However, the mechanisms underlying the crosstalk of CD44 with stemness genes in CSC maintenance remains unclear. In this study, we demonstrated how the cleaved intracellular domain of CD44 (CD44ICD) activates stemness factors such as Nanog, Sox2 and Oct4, and contributes to the tumorigenesis of breast cancer. We have found that the overexpression of CD44ICD increased mammosphere formation in breast cancer cells. Treatment with a γ-secretase inhibitor (GSI), which blocks the cleavage of CD44ICD, interfered with mammosphere formation. Interestingly, CD44ICD decreased the expression levels and nuclear localization of stemness factors, but overexpression of CD44ICD reversed these effects. In addition, we showed that nuclear localization of CD44ICD is important for transcriptional activation of the stemness factors. Furthermore, CD44ICD-overexpressed cells exhibited strong tumorigenecity and greater metastatic potential than did the control cells or CD44-depleted cells in vivo in mice models. Taken together, it was supposed that CD44 promotes tumorigenesis through the interaction and nuclear-translocation of its intracellular domain and stemness factors. We suggest that the prevention of cleavage and nuclear-translocation of CD44ICD is a potential target in treating breast cancer.

AB - CD44 plays a role in the progression of tumors and is expressed in cancer stem cells (CSCs). However, the mechanisms underlying the crosstalk of CD44 with stemness genes in CSC maintenance remains unclear. In this study, we demonstrated how the cleaved intracellular domain of CD44 (CD44ICD) activates stemness factors such as Nanog, Sox2 and Oct4, and contributes to the tumorigenesis of breast cancer. We have found that the overexpression of CD44ICD increased mammosphere formation in breast cancer cells. Treatment with a γ-secretase inhibitor (GSI), which blocks the cleavage of CD44ICD, interfered with mammosphere formation. Interestingly, CD44ICD decreased the expression levels and nuclear localization of stemness factors, but overexpression of CD44ICD reversed these effects. In addition, we showed that nuclear localization of CD44ICD is important for transcriptional activation of the stemness factors. Furthermore, CD44ICD-overexpressed cells exhibited strong tumorigenecity and greater metastatic potential than did the control cells or CD44-depleted cells in vivo in mice models. Taken together, it was supposed that CD44 promotes tumorigenesis through the interaction and nuclear-translocation of its intracellular domain and stemness factors. We suggest that the prevention of cleavage and nuclear-translocation of CD44ICD is a potential target in treating breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84928717089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928717089&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.3325

DO - 10.18632/oncotarget.3325

M3 - Article

C2 - 25909162

AN - SCOPUS:84928717089

VL - 6

SP - 8709

EP - 8721

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 11

ER -